Crimson Health
Crimson Health provides subscription-based GLP-1 therapy and preventive care, combining lab results, wearable data, and treatment history through its AI-driven Crimson Intelligence platform. All treatment protocols are reviewed by University of Utah Health physicians and updated as new evidence emerges. Members can contribute de-identified biomarker data to an IRB-approved research program with the University of Utah.
- Healthcare Technology
- Digital Health
- Artificial Intelligence
- Software Only
Funding
Founders
Founder details are not available yet.
Product
Problem
Access to GLP-1 therapy is often expensive and fragmented, with patients struggling to coordinate lab work, wearable health data, and treatment history into a coherent care plan. Many programs offer one-size-fits-all protocols without ongoing clinical oversight or evidence-based updates, leaving patients to guess whether their treatment is actually working.
Solution
Crimson Health offers subscription-based GLP-1 therapy and preventive care through an AI-driven platform called Crimson Intelligence, which reads lab results against wearable data and protocol history to deliver personalized, actionable health answers. Every treatment protocol is reviewed by University of Utah Health physicians and revised as new research emerges, ensuring clinically vetted recommendations. Members can ask questions about their health and receive responses grounded in their own biomarker data. The service also operates under an IRB-approved research protocol, allowing members to contribute de-identified data to longitudinal healthspan research while gaining early access to developing treatment protocols.
Target Audience
Primary customers are individuals seeking affordable GLP-1 therapy and preventive care who want data-driven, clinically reviewed treatment protocols, including those interested in contributing to healthspan research.
Features
- Crimson Intelligence AI platform that connects lab results, wearable biomarkers, and treatment history for personalized health answers
- Compounded GLP-1 therapy starting at $149–$249/month depending on dose, with branded options available via pharmacy pickup for a $99 access fee
- All treatment protocols reviewed by University of Utah Health physicians and updated as evidence changes
- IRB-approved research protocol enabling members to contribute de-identified biomarker data to healthspan science
- Early access to developing treatment protocols for interested members
- Baseline health assessment with physician interpretation, integrated with wearable device data